Lisa M. Shewchuk

5.2k citations

45 papers · 3.0k indexed · 1 hit paper · h-index 27

Molecular Biology top 5%
Oncology top 5%
Organic Chemistry top 5%
Pulmonary and Respiratory Medicine top 10%
Radiology, Nuclear Medicine and Imaging top 5%

Co-authors: Anne M. Hassell Byron Ellis David W. Rusnak Edgar R. Wood Anne T. Truesdale Krystal J. Alligood Tona M. Gilmer Karen Lackey
Topics: Bone Metabolism and Diseases (8 papers)Signaling Pathways in Disease (6 papers)Natural product bioactivities and synthesis (5 papers)
Cited by: Oncology Organic Chemistry Molecular Biology
Journals: Cell Proceedings of the National Academy of Sciences PLoS ONE
Partner nations: United States Japan Canada

In The Last Decade

Lisa M. Shewchuk

45 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Unique Structure for Epidermal Growth Factor Receptor Bound to GW572016 (Lapatinib)

2004 881 citations Edgar R. Wood, Anne T. Truesdale et al. Cancer Research profile →

Peers

Countries citing papers authored by Lisa M. Shewchuk

Since Specialization

Citations

This map shows the geographic impact of Lisa M. Shewchuk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa M. Shewchuk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa M. Shewchuk more than expected).

Fields of papers citing papers by Lisa M. Shewchuk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa M. Shewchuk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa M. Shewchuk. The network helps show where Lisa M. Shewchuk may publish in the future.

Co-authorship network of co-authors of Lisa M. Shewchuk

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa M. Shewchuk. A scholar is included among the top collaborators of Lisa M. Shewchuk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa M. Shewchuk. Lisa M. Shewchuk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	GSK114: A selective inhibitor for elucidating the biological role of TNNI3K 2016 ·Bioorganic & Medicinal Chemistry Letters ·Brian G. Lawhorn,(unknown),Alan P. Graves,Lisa M. Shewchuk,Dennis A. Holt,Gregory J. Gatto,Lara S. Kallander	13
2	Impact of Common Epidermal Growth Factor Receptor and HER2 Variants on Receptor Activity and Inhibition by Lapatinib 2008 ·Cancer Research ·Tona M. Gilmer,(unknown),Krystal J. Alligood,David W. Rusnak,Glenn Spehar,Kathleen T. Gallagher,(unknown),(unknown),Anne T. Truesdale,Lisa M. Shewchuk,Edgar R. Wood	51
3	Imidazo[5,1-f][1,2,4]triazin-2-amines as novel inhibitors of polo-like kinase 1 2008 ·Bioorganic & Medicinal Chemistry Letters ·Mui Cheung,Kevin W. Kuntz,(unknown),James M. Salovich,Bart J. Wilson,C. Webster Andrews,Lisa M. Shewchuk,Andrea H. Epperly,Daniel F. Hassler,M. Anthony Leesnitzer,Jeffery L. Smith,Gail K. Smith,Timothy J. Lansing,Robert A. Mook	9
4	5-(1H-Benzimidazol-1-yl)-3-alkoxy-2-thiophenecarbonitriles as potent, selective, inhibitors of IKK-ε kinase 2006 ·Bioorganic & Medicinal Chemistry Letters ·Paul Bamborough,J.A. Christopher,Geoffrey J. Cutler,Marion C. Dickson,Geoffrey W. Mellor,J. V. Morey,Champa Patel,Lisa M. Shewchuk	43
5	Novel, potent P2–P3 pyrrolidine derivatives of ketoamide-based cathepsin K inhibitors 2006 ·Bioorganic & Medicinal Chemistry Letters ·David G. Barrett,John G. Catalano,David N. Deaton,Anne M. Hassell,Stacey T. Long,Aaron B. Miller,Larry R. Miller,John A. Ray,Vicente Sámano,Lisa M. Shewchuk,Kevin J. Wells‐Knecht,Derril H. Willard,Lois L. Wright	16
6	Crystallization of protein–ligand complexes 2006 ·Acta Crystallographica Section D Biological Crystallography ·Anne M. Hassell,Gang An,Randy K. Bledsoe,Jane M. Bynum,H. Luke Carter,Su-Jun Deng,Robert T. Gampe,(unknown),Kevin P. Madauss,Robert T. Nolte,Warren J. Rocque,Liping Wang,Kurt Weaver,Shawn P. Williams,G. Bruce Wisely,Robert X. Xu,Lisa M. Shewchuk	120
7	Novel and potent cyclic cyanamide-based cathepsin K inhibitors 2005 ·Bioorganic & Medicinal Chemistry Letters ·David N. Deaton,Anne M. Hassell,Robert B. McFadyen,Aaron B. Miller,Larry R. Miller,Lisa M. Shewchuk,Francis X. Tavares,Derril H. Willard,Lois L. Wright	31
8	Semicarbazone-based inhibitors of cathepsin K, are they prodrugs for aldehyde inhibitors? 2005 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),David G. Barrett,David N. Deaton,Robert T. Gampe,Anne M. Hassell,Stacey T. Long,Robert B. McFadyen,Aaron B. Miller,Larry R. Miller,(unknown),Lisa M. Shewchuk,Kevin J. Wells‐Knecht,Derril H. Willard,Lois L. Wright	12
9	A Unique Structure for Epidermal Growth Factor Receptor Bound to GW572016 (Lapatinib)breakdown → 2004 ·Cancer Research ·Edgar R. Wood,Anne T. Truesdale,Octerloney B. McDonald,Derek Yuan,Anne M. Hassell,Scott H. Dickerson,Byron Ellis,(unknown),(unknown),Karen Lackey,Krystal J. Alligood,David W. Rusnak,Tona M. Gilmer,Lisa M. Shewchuk	881
10	Potent and selective P2–P3 ketoamide inhibitors of cathepsin K with good pharmacokinetic properties via favorable P1′, P1, and/or P3 substitutions 2004 ·Bioorganic & Medicinal Chemistry Letters ·David G. Barrett,John G. Catalano,David N. Deaton,Anne M. Hassell,Stacey T. Long,Aaron B. Miller,Larry R. Miller,Lisa M. Shewchuk,Kevin J. Wells‐Knecht,Derril H. Willard,Lois L. Wright	24
11	Exploration of the P2–P3 SAR of aldehyde cathepsin K inhibitors 2004 ·Bioorganic & Medicinal Chemistry Letters ·Eric E. Boros,David N. Deaton,Anne M. Hassell,Robert B. McFadyen,Aaron B. Miller,Larry R. Miller,Margot G. Paulick,Lisa M. Shewchuk,James B. Thompson,Derril H. Willard,Lois L. Wright	27
12	アルデヒド系カテプシンK阻害剤のP 1 部位SAR探究 2004 ·Bioorganic & Medicinal Chemistry Letters ·John G. Catalano,David N. Deaton,Eric S. Furfine,(unknown),Robert B. McFadyen,Larry R. Miller,Lisa M. Shewchuk,Derril H. Willard,Lois L. Wright	26
13	Exploration of the P1 SAR of aldehyde cathepsin K inhibitors 2003 ·Bioorganic & Medicinal Chemistry Letters ·John G. Catalano,David N. Deaton,Eric S. Furfine,Annie M. Hassell,Robert B. McFadyen,Aaron B. Miller,Larry R. Miller,Lisa M. Shewchuk,Derril H. Willard,Lois L. Wright	32
14	Anilinopyrazole as selective CDK2 inhibitors 2003 ·Bioorganic & Medicinal Chemistry Letters ·Jun Tang,Lisa M. Shewchuk,Hideyuki Sato,Masaichi Hasegawa,Yoshiaki Washio,(unknown)	34
15	The Drosophila Orphan Nuclear Receptor DHR38 Mediates an Atypical Ecdysteroid Signaling Pathway 2003 ·Cell ·K.D. Baker,Lisa M. Shewchuk,Tatiana Kozlova,Makoto Makishima,Annie M. Hassell,Bruce Wisely,Justin A. Caravella,Millard H. Lambert,Jeffrey Reinking,Henry M. Krause,Carl S. Thummel,Timothy M. Willson,David J. Mangelsdorf	182
16	Structure of the Tie2 RTK Domain 2000 ·Structure ·Lisa M. Shewchuk,Anne M. Hassell,Byron Ellis,William D. Holmes,(unknown),(unknown),Sue H. Kadwell,David D. McKee,John T. Moore	113
17	The formation of a covalent complex between a dipeptide ligand and the src SH2 domain 1998 ·Bioorganic & Medicinal Chemistry Letters ·Krystal J. Alligood,Paul S. Charifson,Renae M. Crosby,Thomas G. Consler,Paul L. Feldman,Robert T. Gampe,Tona M. Gilmer,Steven R. Jordan,(unknown),Christopher Mohr,Michael Peel,Warren J. Rocque,(unknown),David W. Rusnak,Lisa M. Shewchuk,Daniel D. Sternbach	13
18	Structure of a hinge-bending bacteriophage T4 lysozyme mutant, Ile3 → Pro 1992 ·Journal of Molecular Biology ·M.M. Dixon,H. Nicholson,Lisa M. Shewchuk,W.A. Baase,Brian W. Matthews	69
19	Transcriptional switching by the MerR protein: activation and repression mutants implicate distinct DNA and mercury(II) binding domains 1989 ·Biochemistry ·Lisa M. Shewchuk,John D. Helmann,Wilma Ross,Soon‐Jung Park,Anne O. Summers,Christopher T. Walsh	50
20	Transcriptional switching by the metalloregulatory MerR protein: initial characterization of DNA and mercury(II) binding activities 1989 ·Biochemistry ·Lisa M. Shewchuk,Gregory L. Verdine,C T Walsh	55

About Lisa M. Shewchuk

Lisa M. Shewchuk is a scholar working on Immunology and Allergy, Physiology and Oncology, having authored 45 papers that have together received 3.0k indexed citations. Recurring topics across this work include Bone Metabolism and Diseases (8 papers), Signaling Pathways in Disease (6 papers) and Natural product bioactivities and synthesis (5 papers). The work is most often cited by research in Oncology (899 citations), Organic Chemistry (690 citations) and Molecular Biology (1.6k citations). Lisa M. Shewchuk has collaborated with scholars based in United States, Japan and Canada. Frequent co-authors include Anne M. Hassell, Byron Ellis, David W. Rusnak, Edgar R. Wood, Anne T. Truesdale, Krystal J. Alligood, Tona M. Gilmer, Karen Lackey, Scott H. Dickerson and Octerloney B. McDonald. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact